Mednet Logo
HomeRadiation OncologyQuestion

Would you use upfront atezo/bev in a patient with HCC and untreated hepatitis?

3 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Colorado School of Medicine

In the case of a patient with untreated chronic hepatitis C, I would offer upfront atezo/bev, as long as hepatic function is appropriate. At our center, hepatitis C treatment is generally not offered to patients with advanced HCC.

Interestingly, only 21% of patients treated with atezolizumab/bevaciz...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Geffen School of Medicine at UCLA

Yes. I would not have concerns. For HBV, I would start treatment before or simultaneously. Studies have varied by protocol about the HBV viral load being under 500 or 100 but it is not clear this matters. There have not been flairs reported. In regards to HCV, again, not an issue for me.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Keck School of Medicine of USC

Patients with hepatitis B should be on antiviral therapy with HBV DNA level of 500 or less; all trials with immune checkpoint inhibitors have had such a requirement. There are no limitations or special requirements in regards to treatment of Patients for hepatitis C prior to initiation of hepatitis ...

Register or Sign In to see full answer